Infectious complications from high-dose chemotherapy and autologous stem cell transplantation for metastatic germ cell tumors Journal Article


Authors: Jathavedam, A.; Feldman, D. R.; Ishill, N.; Turkula, S.; Patil, S.; Bosl, G. J.; Motzer, R. J.; Weinstock, D. M.
Article Title: Infectious complications from high-dose chemotherapy and autologous stem cell transplantation for metastatic germ cell tumors
Abstract: High-dose chemotherapy with autologous stem cell transplantation (ASCT) is increasingly utilized in patients with relapsed and refractory germ cell tumors (GCT). Infectious complications are common after ASCT for hematologic malignancies, but their epidemiology in GCT patients has not been described. To identify infectious complications of ASCT for GCT, we conducted a retrospective study of patients treated at our institution, a tertiary-care cancer center in New York City between 1994 and 2006. Patients received ciprofloxacin prophylaxis but no routine antifungal or antiviral prophylaxis. In addition, patients were housed in shared rooms of 2 with standard precautions during hospitalizations. Overall, 107 patients with relapsed or refractory GCT were treated with 1-2 cycles of paclitaxel/ifosfamide and 1-3 cycles of high-dose carboplatin/etoposide with ASCT. Sixty (56%) of 107 patients developed 95 total infections, including 33 catheter-associated bloodstream infections. Fungal, viral, and nosocomial infections were uncommon. There were no infection-related deaths. In conclusion, serious morbidity from infection is uncommon among GCT patients receiving high-dose chemotherapy with ASCT. Isolation and aggressive antifungal and antiviral prophylaxis is not warranted in these patients. © 2008 American Society for Blood and Marrow Transplantation.
Keywords: adolescent; adult; controlled study; middle aged; cancer surgery; retrospective studies; major clinical study; neutropenia; cisplatin; drug withdrawal; united states; paclitaxel; cancer radiotherapy; drug megadose; antineoplastic agent; carboplatin; metastasis; infection; multiple cycle treatment; etoposide; antineoplastic combined chemotherapy protocols; morbidity; aciclovir; autologous stem cell transplantation; herpes simplex; herpes zoster; hematopoietic stem cell transplantation; retrospective study; ifosfamide; drug fever; hospitalization; death; urinary tract infection; ciprofloxacin; neoplasm metastasis; cancer relapse; colitis; enteritis; neoplasms, germ cell and embryonal; bacteremia; virus infection; hospital infection; recombinant granulocyte colony stimulating factor; levofloxacin; catheter infection; influenza; antibiotic prophylaxis; germ cell tumor; transplantation, autologous; seminoma; mycosis; voriconazole; chickenpox; non seminomatous germinoma; cellulitis; premedication; infectious complication; transplant; otitis media; bacterial pneumonia; pharyngitis; high-dose chemotherapy; esophagus candidiasis; ivermectin; autologous; external otitis; infectious complications; lung mycosis; neutropenic enterocolitis; peritonsillar abscess; skin abscess; strongyloidiasis; tooth abscess
Journal Title: Biology of Blood and Marrow Transplantation
Volume: 14
Issue: 5
ISSN: 1083-8791
Publisher: Elsevier Inc.  
Date Published: 2008-05-01
Start Page: 595
End Page: 600
Language: English
DOI: 10.1016/j.bbmt.2008.02.020
PUBMED: 18410903
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 2" - "Export Date: 17 November 2011" - "CODEN: BBMTF" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sujata Patil
    511 Patil
  2. Robert Motzer
    1243 Motzer
  3. Darren Richard Feldman
    340 Feldman
  4. George Bosl
    430 Bosl
  5. Nicole Marie Leoce
    86 Leoce